2nd International Conference on CRISPR Technologies

December 10-12, 2018
Add to Calendar

Presented by the Society for Biological Engineering (SBE), this conference will bring together leaders and trainees from the cutting edge of CRISPR technologies and their application to genome editing and beyond. Academic, clinical, and industrial researchers are invited to share their recent discoveries to progress the field in CRISPR science and engineering.

Call for abstracts is now open until September 10, 2018

Submit an abstract

"Save the date" flyer

CRISPR technologies have been widely embraced for both basic and applied research. This space has rapidly moved forward since the first demonstration of Cas9-mediated genome editing with the discovery of new nucleases, the development of diverse and novel CRISPR applications for genome editing, gene regulation, in vitro applications, and the use of CRISPR technologies in diverse organisms, including, prokarynotes, plants, and animals.

Keynote Speakers

Invited Speakers

Session Topics

  • CRISPR-Cas biology
  • Genome editing and DNA repair
  • Clinical applications of CRISPR
  • Beyond editing: novel applications
  • CRISPR-based gene drives
  • Delivery and specificity of CRISPR-based tools
  • Social, ethical, and economic implications of CRISPR-based technologies

Conference Chairs

Organizing Committee

Featured Speakers

Omar Akbari

In May of 2005, Omar S. Akbari received a B.S./M.S. in Biotechnology from the University of Nevada, Reno. In December of 2008, he received a Ph.D. in Cell and Molecular Biology from the University of Nevada, Reno where he studied the role cis-regulatory modules play in cellular identity along the anterio-posterior axis in developing Drosophila melanogaster embryos. In fall of 2017, he joined the faculty as an Assistant Professor in the Cell and Developmental Biology Section, within the Division of Biological Sciences, and a member of the TATA institute for Genetics and Society at the University of California, San Diego.Read more

Charles Gersbach

Dr. Charles A. Gersbach is the Rooney Family Associate Professor at Duke University in the Departments of Biomedical Engineering and Orthopaedic Surgery, an Investigator in the Duke Center for Genomic and Computational Biology, and Director of the Duke Center for Biomolecular and Tissue Engineering.Read more

Patrick Hsu

Patrick is a Principal Investigator and Salk Helmsley Fellow at the Salk Institute for Biological Studies. He received his B.A. from the University of California, Berkeley, as well as A.M. and Ph.D. degrees from Harvard University. Working with Feng Zhang and Xiaowei Zhuang at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT, he contributed to the early development of CRISPR-Cas9 genome engineering technologies for efficient and precise application in eukaryotic cells.Read more

Yinan Kan

Yinan Kan is the Principle Scientist in the eGenesis gene editing team. He received his Ph.D. degree in 2015 in Biochemistry, Molecular Biology and Biophysics in the University of Minnesota with a research focus of dissecting the DNA repair pathways underlying homology-directed genome editing. He conducted postdoc research at Harvard Medical School before joining eGenesis Inc. He is devoted to developing novel technological platforms for multiplexed, precision and long-range genome editing with the aim of delivering safe and effective human transplantable organs from...Read more

Prashant Mali

Prashant Mali received a bachelor’s and master’s in Electrical Engineering from the Indian Institute of Technology Bombay, with a research focus on solid-state biosensors; and a doctorate in Biomedical Engineering at the Johns Hopkins University, with a research focus on human pluripotent stem cell engineering. During his postdoctoral fellowship in the Department of Genetics at the Harvard Medical School, he pioneered the development of the CRISPR-Cas systems for eukaryotic genome engineering. For his graduate work he received the Siebel Scholar Award in 2011, and in 2014 he...Read more

Megan Palmer

Dr. Megan J. Palmer is a Senior Research Scholar at the Center for International Security and Cooperation (CISAC) at Stanford University. She leads a research and practice program on risk governance in emerging technology development, with a focus on how security is conceived and managed as biotechnology becomes increasing accessible. Her current projects focus on assessing strategies for governing dual use research, analyzing the international diffusion of safety norms and practices, and the understanding the security implications of alternative technology design decisions.Read more

Fyodor Urnov

Fyodor Urnov, Ph.D., is Deputy Director at the Altius Institute for Biomedical Sciences, where he shares broad responsibility for defining and leading the overall scientific effort. He is an author of more than 70 scientific publications and an inventor on more than 130 issued and pending U.S. patents related to genome editing and targeted gene regulation technology.Read more

Harris Wang

Harris Wang is an Assistant Professor at Columbia University jointly appointed in the Department of Systems Biology and the Department of Pathology and Cell Biology. Dr. Wang received his B.S. degrees in Mathematics and Physics from MIT and his Ph.D. in Biophysics from Harvard University.Read more